Policy and Advocacy News 2
Policy and Advocacy News
-
amfAR at AIDS 2024
amfAR puts people-centered research first at the 25th International AIDS Conference.
-
AIDS Amnesia
Dwindling political support for global and domestic HIV programs will put women’s lives at risk.
-
Two Diseases, One Response
New amfAR policy brief highlights the intersection between HIV, HPV, and cervical cancer with an emphasis on co-investment opportunities to advance elimination goals worldwide
-
RISE Up!
Findings from the RISE study underscore the importance of community engagement in Global Fund grantmaking processes.
-
2023: Milestones, Roadblocks, and the Path Ahead
The advances and setbacks of 2023 have set the stage for a turbulent year ahead.
-
PrEP Usage in U.S. Hits Historic Highs, But Disparities Persist
Barriers to access prevent marginalized populations from the benefits of the HIV prevention tool.
-
How Can We Advance Equity in Mpox Diagnostics?
amfAR and the NYC Pandemic Response Institute asked stakeholders to strategize about how best to achieve mpox equity access in diagnostics.
-
Zero Out the Epidemic—Not the Budget
amfAR and FCAA fight to protect proposed cuts to HIV/AIDS federal funding that would reverse progress in ending the HIV epidemic.
-
Understanding the Barriers to HIV Care
A new study analyzes people living with HIV who are not regularly engaged in care in order to meet their needs and dismantle healthcare barriers.
-
amfAR Condemns Uganda’s Draconian Anti-LGBTQ+ Law
Uganda’s harsh new anti-LGBTQ+ law will reverse hard-won progress in HIV treatment and prevention, amfAR and other advocates fear.
-
Failing to Learn the Lessons: The U.S. Response on Global Health Security Ignores 20 Years of PEPFAR
amfAR warns the U.S. government’s proposed reconfiguration of global health functions will negatively impact PEPFAR, which has so far been a success.
-
Partners in Progress: amfAR Meets with PEPFAR Ambassador
Ahead of PEPFAR’s reauthorization, amfAR’s public policy team met with its head, Ambassador John Nkengasong, to discuss the future of the most successful global health program ever.
-
Learning from Mpox
In a new policy brief, amfAR and the O’Neill Institute discuss what mpox taught us about responding to public health threats.
-
Standing with the Transgender Community
From HIV advocacy to research, amfAR believes that meaningful inclusion of transgender people is essential to the fight against AIDS.
-
amfAR Welcomes Revised Policy on Blood Donations but Urges FDA To Take Further Steps Toward Equitable Treatment for Gay and Bisexual Men
New policy bars people taking PrEP from donating blood despite negligible risk of HIV infection.